Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

DGX - Quest Diagnostics, Inc.


168.82
2.400   1.422%

Share volume: 1,447,794
Last Updated: 03-13-2025
Healthcare/Services – Health: -0.05%

PREVIOUS CLOSE
CHG
CHG%

$166.42
2.40
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
69%
Profitability 69%
Dept financing 38%
Liquidity 15%
Performance 92%
Company vs Stock growth
vs
Performance
5 Days
-2.48%
1 Month
0.03%
3 Months
10.59%
6 Months
7.97%
1 Year
32.80%
2 Year
26.08%
Key data
Stock price
$168.82
P/E Ratio 
19.24
DAY RANGE
$165.76 - $169.42
EPS 
$7.78
52 WEEK RANGE
$125.42 - $178.87
52 WEEK CHANGE
$31.60
MARKET CAP 
16.756 B
YIELD 
1.97%
SHARES OUTSTANDING 
111.317 M
DIVIDEND
$0.75
EX-DIVIDEND DATE
07-08-2024
NEXT EARNINGS DATE
N/A
BETA 
0.29
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,350,106
AVERAGE 30 VOLUME 
$1,251,564
Company detail
CEO: James E. Davis
Region: US
Website: questdiagnostics.com
Employees: 49,000
IPO year: 1996
Issue type: Common Stock
Market: NYSE
Industry: Healthcare/Services – Health
Sector: Services

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic info services. It also provides risk assessment services for life insurance industry; and healthcare organizations and clinicians robust information technology solutions.

Recent news